Synapse - Department of Medicine

Results (611)

Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses

Journal Article

Moore, A.; Kane, E.; Teras, L. R.; Machiela, M. J.; Arias, J.; Panagiotou, O. A.; Monnereau, A.; Doo, N. W.; Wang, Z.; Slager, S. L.; more...
International Journal of Cancer (2025)

Fulltext@MSK | Save

Haematotoxicity risk factors for sub-optimal outcomes following obecabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukaemia

Meeting Abstract

Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Tholouli, E.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

BRUIN CLL-321: Randomized phase III trial of pirtobrutinib versus idelalisib+rituximab or bendamustine+rituximab in BTKi-pretreated CLL/SLL

Meeting Abstract

Sharman, J. P.; Munir, T.; Grosicki, S.; Roeker, L. E.; Burke, J. M.; Chen, C.; Grzasko, N.; Follows, G.; Mátrai, Z.; Sanna, A.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

Tumour burden-guided dosing in the FELIX study of obecabtagene autoleucel in adult R/R B-ALL

Meeting Abstract

Yallop, D.; Jabbour, E.; Sandhu, K. S.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B. D.; Bishop, M. R.; Park, J. H.; DeAngelo, D. J.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

Obecabtagene autoleucel with/without consolidative stem cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukaemia: Patient outcomes

Meeting Abstract

Tholouli, E.; Park, J. H.; Jabbour, E.; Shah, B. D.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Bishop, M. R.; DeAngelo, D. J.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

Safety of tyrosine kinase inhibitor discontinuation for pregnancy in patients with established chronic myeloid leukaemia

Meeting Abstract

Chan, C. N. J.; Robertson, H. F.; Apperley, J. F.; Milojkovic, D.; Innes, A.; Claudiani, S.; Khan, A.; Abruzzese, E.; Mauro, M.; Mahdi, A.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

MagnetisMM-3: Long-term update and outcomes of less frequent dosing of elranatamab in relapsed/refractory multiple myeloma

Meeting Abstract

Searle, E.; Prince, H. M.; Bahlis, N.; Rodriguez-Otero, P.; Karlin, L.; Akard, L.; Varshavsky-Yanovsky, A.; Nagai, Y.; Vesole, D.; Chu, M.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

Pirtobrutinib in relapsed/refractory CLL/SLL: Results from BTKi naïve cohort in the phase 1/2 BRUIN study

Meeting Abstract

Munir, T.; Eyre, T.; Lech-Maranda, E.; Roeker, L. E.; Patel, M.; Fukuhara, N.; Woyach, J. A.; Wierda, W. G.; Brown, J. R.; Patel, K.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

Depth of MRD-negative remission and outcomes in adults with R/R B-ALL treated with obecabtagene autoleucel

Meeting Abstract

Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Tholouli, E.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save

Five-year POLARIX analysis confirms positive impact of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone

Meeting Abstract

Collins, G.; Salles, G.; Morschhauser, F.; Sehn, L. H.; Herrera, A. F.; Friedberg, J. W.; Trněný, M.; Lenz, G.; Sharman, J. P.; Herbaux, C.; more...
British Journal of Haematology (2025)

Fulltext@MSK | Save